Clalit Health Services Data2Life has an exclusive partnership with Clalit Health Services, the world’s 2nd-largest HMO unique in having an integrated, centralized Electronic Health Records (EHR) data system in practically all of its community care clinics, pharmacies and labs, for almost two decades in over 4.5 million patients. This data included detailed and full demographic, diagnoses, lab results, costs per patients, drugs (both prescription and dispensing data) and administrative data. Clalit is the owner of 14 public hospitals and over 1,400 community clinics throughout Israel. In 2010, Clalit launched its Research Institute, which now holds over 18 professionals of multidisciplinary qualifications – top notch clinicians, epidemiologists, biostatisticians, IT experts, algorithm specialists and public health experts. The institute associates gained invaluable experience in mining and interpreting the organizational database. These tools allowed for implementing innovative clinical interventions to tackle key health issues such as reducing healthcare disparities, preventing avoidable readmissions, tackling inadequate treatment adherence, assessing the impact of multi-morbidity, improving control of key chronic diseases, performing comparative effectiveness real-life studies and using predictive modeling and advanced analytics to allow targeted care in high risk groups. Clalit Research Institute has been recently designated by the WHO as one of the 10 Collaborating Centers for chronic diseases research and prevention. Starting October 2017, the Clalit Research Institute has gained access to Data2Life 360 Safety surveillance tool and is using it to achieve key safety goals. The Clalit Research is also a Data2Life long-term strategic partner. Kantar Health Our partnership with Kantar Health, a leading global healthcare consulting firm, has allowed Data2Life to provide early signal intelligence on drug side effects based on “real-world” information to the pharmaceutical industry. Multilayered data combined with machine learning and analysis will give pharmaceutical and biotech companies timely indicators to strengthen pharmacovigilance and risk management, reveal innovation opportunities and optimize clinical trial design. Kantar Health serves as a trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership. IQVIA IQVIA is Human Data Science Company committed to providing solutions that enable healthcare companies to innovate with confidence, maximize opportunities and, ultimately, drive healthcare forward. This is done via breakthroughs in insights, technology, analytics and human intelligence that bring the advances in data science together with the possibilities of human science. To achieve this holistic approach, IQVIA strives to generate unique perspectives that are used to create solutions for customers. Data2Life and IQVIA are collaborating to rethink innovative approaches to clinical development, post-marketing safety and product commercialization. Our common mission is to reframe old Healthcare challenges into new opportunities, and re-imagine the future of the BioPharma industry .